Bulletin
Investor Alert

Protagonist Therapeutics Inc.

NAS: PTGX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 24, 2023, 6:10 p.m.

/zigman2/quotes/205674595/composite

$

20.94

Change

+0.21 +1.01%

Volume

Volume 16,527

Quotes are delayed by 20 min

/zigman2/quotes/205674595/composite

Previous close

$ 21.01

$ 20.73

Change

-0.28 -1.33%

Day low

Day high

$20.41

$21.02

Open

52 week low

52 week high

$6.91

$26.00

Open

Insider Actions for Protagonist Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/16/2023 Suneel Gupta
Chief Development Officer
20,625   Award at $0 per share. 0
01/16/2023 Arturo Molina
Chief Medical Officer
3,125   Award at $0 per share. 0
01/16/2023 Asif Ali
Chief Financial Officer
10,625   Award at $0 per share. 0
12/28/2022 Dinesh V. Patel
President and CEO; Director
3,116   Gift at $0 per share. 0
11/16/2022 David Y. Liu
Chief R&D Strategy Officer
35,331   Derivative/Non-derivative trans. at $4.21 per share. 148,743
11/16/2022 David Y. Liu
Chief R&D Strategy Officer
35,656   Derivative/Non-derivative trans. at $1.16 per share. 41,360
11/16/2022 David Y. Liu
Chief R&D Strategy Officer
5,999   Derivative/Non-derivative trans. at $1.89 per share. 11,338
11/16/2022 David Y. Liu
Chief R&D Strategy Officer
9,726   Derivative/Non-derivative trans. at $1.89 per share. 18,382
11/16/2022 David Y. Liu
Chief R&D Strategy Officer
13,767   Derivative/Non-derivative trans. at $0.87 per share. 11,977
11/15/2022 Arturo Molina
Chief Medical Officer
21,250   Award at $0 per share. 0
08/23/2022 Dinesh V. Patel
President and CEO; Director
20,000   Derivative/Non-derivative trans. at $4.21 per share. 84,200
05/04/2022 Dinesh V. Patel
President and CEO; Director
3,000   Gift at $0 per share. 0
05/04/2022 Dinesh V. Patel
President and CEO; Director
15,742   Derivative/Non-derivative trans. at $4.21 per share. 66,273
05/03/2022 William D. Waddill
Director
12,000   Derivative/Non-derivative trans. at $8.59 per share. 103,080
04/26/2022 Dinesh V. Patel
President and CEO; Director
30,000   Derivative/Non-derivative trans. at $4.21 per share. 126,300
04/26/2022 Suneel Gupta
Chief Development Officer
40,000   Derivative/Non-derivative trans. at $7.38 per share. 295,200
04/18/2022 Asif Ali
Chief Financial Officer
13,750   Award at $0 per share. 0
04/14/2022 Dinesh V. Patel
President and CEO; Director
34,087   Derivative/Non-derivative trans. at $1.89 per share. 64,424

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
3 Purchases
1 Sales
34,375
3,116
Last 6 months
9 Purchases
1 Sales
156,104
3,116
Last 12 months
16 Purchases
2 Sales
321,683
6,116

Officers and Executives

Dr. Dinesh V. Patel
President, Chief Executive Officer & Director
Mr. Asif Ali
Chief Financial Officer & Executive Vice President
Dr. Mohammad Masjedizadeh
Chief Technical officer & Executive VP
Dr. Arturo Molina
Chief Medical Officer
Dr. Samuel R. Saks
Advisor-Clinical Development
Dr. Scott Plevy
Executive Vice President & Head-Gastroenterology
Mr. Jami Taylor
Vice President-Corporate Affairs
Dr. Ashok Bhandari
Senior Director-Chemistry
Mr. Carter J. King
Vice President-Business Development
Dr. Suneel Gupta
Chief Development Officer
Ms. Carena Spivey
Executive Director-Human Resources
Mr. Matthew M. Gosling
Executive Vice President & General Counsel
Dr. Mark L. Smythe
Vice President-Technology
Dr. Harold E. Selick
Chairman
Ms. Sarah A. O'Dowd
Independent Director
Mr. William D. Waddill
Independent Director
Dr. Lewis T. Williams
Independent Director
Dr. Sarah B. Noonberg
Independent Director
Mr. Bryan Giraudo
Independent Director
Link to MarketWatch's Slice.